Loading...
Price History
Market Data
| Market Cap | 5.78B |
| P/E Ratio | 17.43 |
| P/B Ratio | 3.34 |
| EPS | 2.01 |
| Dividend Yield | - |
| D/E Ratio | 0.34 |
| Current Ratio | 3.67 |
| Currency | USD |
Key Financial Metrics
1.52B
Revenue
338.83M
Net Income
2.01
EPS (Diluted)
805.46M
Free Cash Flow
Profitability
Gross Margin
86.0%
Operating Margin
23.6%
Net Profit Margin
22.3%
EBITDA
411.37M
Returns & Efficiency
Return on Assets (ROA)
14.5%
Return on Equity (ROE)
19.5%
Dividend Yield
-
EPS
2.01
Financial Health
Total Assets
2.33B
Total Debt
-
Debt to Equity
0.34x
Current Ratio
3.67
Insider Trading
Last 12 months
0
Buys
0
Sells
0
Insiders
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
| Industry | Chemicals & Allied Products |
| HQ | DUBLIN 4 |
| Fiscal Year | 2024 |
Peers
LILLY ELI & CO
LLY
894.82B
P/E: --
ELI LILLY & CO
LLY
894.82B
P/E: --
533.28B
P/E: --
ABBVIE INC.
ABBV
355.49B
P/E: --
BEIGENE, LTD.
BEIGF
306.50B
P/E: 632.4
BEONE MEDICINES LTD.
BEIGF
306.50B
P/E: 632.4
275.14B
P/E: --
MERCK & CO. INC.
MRK
275.14B
P/E: --
Quick Links
Financial Statistics
Valuation
Market Cap$5.78B
P/E Ratio (TTM)17.4
Price to Book3.34
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin86.0%
Operating Margin23.6%
Net Margin22.3%
ROE19.5%
ROA14.5%
Leverage & Liquidity
Debt to Equity0.34
Current Ratio3.67
Total Debt-
Total Assets$2.33B
Stockholders' Equity$1.73B
Income Statement (FY 2024)
Revenue$1.52B
Gross Profit$1.31B
Operating Income$358.54M
Net Income$338.83M
EPS (Diluted)$2.01
Cash Flow (FY 2024)
Free Cash Flow$805.46M
Cash & Equivalents$616.45M
Revenue Growth-
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address | CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4, None 00000 |
| Phone | 00-353-1-772-8000 |
| Incorporated | None, None |
| EIN | 981007018 |
| Fiscal Year End | 1231 |
| Shares Outstanding | 165.09M |
| Stockholders' Equity | $1.73B |
| Cash & Equivalents | $616.45M |
Recent Filings
View All
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-05-05
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2026-05-05
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-05-04
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-05-04
Local
SCHEDULE 13G
Passive Ownership Report
Schedule 13G - passive beneficial ownership
Filed: 2026-04-28
Local
SCHEDULE 13G
Passive Ownership Report
Schedule 13G - passive beneficial ownership
Filed: 2026-04-28
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-13
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-06
Local
ARS
Annual Report to Shareholders
Annual report furnished to shareholders
Filed: 2026-04-06
Local
DEFA14A
Additional Proxy Materials
Additional definitive proxy soliciting materials
Filed: 2026-04-06
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2026-04-06
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-04-06
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-01
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-04-01
Local
SCHEDULE 13G/A
Amended Schedule 13G
Amendment to Schedule 13G
Filed: 2026-03-26
Local
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...
Loading...
Loading short interest data...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
| Company Name | ALKERMES PLC. |
| Ticker | ALKS |
| Exchange | -- |
| Sector | Manufacturing |
| Industry | Chemicals & Allied Products |
| Headquarters | DUBLIN 4 |
| Fiscal Year | 2024 |
Financial Summary
| Market Cap | 5.78B |
| Revenue | 1.52B |
| Net Income | 338.83M |
| P/E Ratio | 17.43 |
| EPS | 2.01 |
| Net Margin | 22.3% |
| ROE | 19.5% |
| Dividend Yield | - |
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...